Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Debt Growth Recovery in ProgressRecovering
Percentile Rank75
3Y CAGR+18.4%
Studio
Year-over-Year Change

Year-over-year debt growth rate

3Y CAGR
+18.4%/yr
Annual compound
Percentile
P75
Within normal range
vs 3Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202531.81%
2024-96.76%
20233202.99%
202219.15%
20210.00%